ALLMedicine™ Severe Acute Respiratory Syndrome Center
Research & Reviews 11,499 results
https://doi.org/10.1080/14767058.2021.1892637
The Journal of Maternal-fetal & Neonatal Medicine : the O... Zhang P, Heyman T et. al.
Mar 1st, 2021 - COVID19 is caused by a newly identified severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) that affects pregnant women equally to the general population. How SARS-CoV2 affects the mothers, the neonates and the placental pathology remain c...
https://doi.org/10.1080/23744235.2021.1890331
Infectious Diseases (London, England); Viceconte G, Buonomo AR et. al.
Mar 1st, 2021 - Several cases of invasive fungal diseases in patients with COVID-19 have been reported, mostly due to Aspergillus spp., with anecdotic reports of Pneumocystis jirovecii pneumonia (PJP) as co-infections in immunocompromised patients. We describe th...
https://doi.org/10.2174/1871526521666210301143441
Infectious Disorders Drug Targets; Leowattana W
Mar 1st, 2021 - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is one of the most infectious diseases and caused coronavirus disease in 2019 (COVID-19). It has been widely spread worldwide and infected more than 28 million peoples in 215 countries, ...
https://doi.org/10.1007/s40266-021-00840-y 10.1016/j.phrs.2020.105250 10.1001/jamainternmed.2020.0994 10.1016/j.jinf.2020.04.008 10.2337/dbi19-0023 10.1016/j.arr.2020.101205 10.2147/TCRM.S272908 10.1371/journal.pone.0238091 10.2196/15385 10.1186/s12877-015-0029-9 10.1007/s40266-020-00812-8 10.3389/fphar.2020.579886 10.1002/rth2.12353 10.1093/ofid/ofaa563 10.1002/cpt.1376 10.2147/TCRM.S259152 10.1007/s11897-020-00485-9 10.1016/j.giec.2019.12.005 10.1001/jama.2020.17021 10.1136/gutjnl-2020-322248
Drugs & Aging; Cattaneo D, Pasina L et. al.
Mar 1st, 2021 - Patients with coronavirus disease 2019 (COVID-19) are often elderly, with comorbidities, and receiving polypharmacy, all of which are known factors for potentially severe drug-drug interactions (DDIs) and the prescription of potentially inappropri...
https://doi.org/10.1002/rmv.2223
Reviews in Medical Virology; Alwani M, Yassin A et. al.
Mar 1st, 2021 - The current coronavirus disease (COVID-19) pandemic caused by novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has a male bias in severity and mortality. This is consistent with previous coronavirus pandemics such as SARS-CoV and...
Guidelines 225 results
https://www.fda.gov/media/146217/download
Vaccines and Related Biological Products Advisory Committee Meeting
Feb 25th, 2021 - On February 4, 2021, Janssen Biotech, Inc. (the Sponsor) submitted an Emergency Use Authorization (EUA) request to FDA for an investigational vaccine intended to prevent COVID19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-...
https://www.nejm.org/doi/full/10.1056/NEJMoa2021801
The New England Journal of Medicine; Mitjà O, Corbacho-Monné M et. al.
Feb 2nd, 2021 - Current strategies for preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are limited to nonpharmacologic interventions. Hydroxychloroquine has been proposed as a postexposure therapy to prevent coronavirus disease 2...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422822/
The Journal of Infection; Tomassini S, Kotecha D et. al.
Jan 31st, 2021 - We read with interest the article by Batisse et al.1 describing 11 possible cases of symptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) reinfection. However, the intervening period of ‘clinical cure’ was not confirmed by a ne...
https://www.acpjournals.org/doi/10.7326/M20-7918
Annals of Internal Medicine; Perez J, Roustit M et. al.
Jan 25th, 2021 - Background: A few weeks after the beginning of the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), uncontrolled trials and in vitro studies suggested that chloroquine and hydroxychloroquine may have efficacy in treating c...
https://onlinelibrary.wiley.com/doi/10.1002/jmv.26764
Journal of Medical Virology; Ho, Y.I. et. al.
Jan 10th, 2021 - To the Editor, Various studies have demonstrated that deep throat saliva (DTS) is comparable with nasopharyngeal (NP) specimens for detection of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) by real‐time polymerase chain reaction.1...
Drugs 1 results see all →
Clinicaltrials.gov 11,857 results
https://doi.org/10.1080/14767058.2021.1892637
The Journal of Maternal-fetal & Neonatal Medicine : the O... Zhang P, Heyman T et. al.
Mar 1st, 2021 - COVID19 is caused by a newly identified severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) that affects pregnant women equally to the general population. How SARS-CoV2 affects the mothers, the neonates and the placental pathology remain c...
https://doi.org/10.1080/23744235.2021.1890331
Infectious Diseases (London, England); Viceconte G, Buonomo AR et. al.
Mar 1st, 2021 - Several cases of invasive fungal diseases in patients with COVID-19 have been reported, mostly due to Aspergillus spp., with anecdotic reports of Pneumocystis jirovecii pneumonia (PJP) as co-infections in immunocompromised patients. We describe th...
https://doi.org/10.2174/1871526521666210301143441
Infectious Disorders Drug Targets; Leowattana W
Mar 1st, 2021 - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is one of the most infectious diseases and caused coronavirus disease in 2019 (COVID-19). It has been widely spread worldwide and infected more than 28 million peoples in 215 countries, ...
https://doi.org/10.1007/s40266-021-00840-y 10.1016/j.phrs.2020.105250 10.1001/jamainternmed.2020.0994 10.1016/j.jinf.2020.04.008 10.2337/dbi19-0023 10.1016/j.arr.2020.101205 10.2147/TCRM.S272908 10.1371/journal.pone.0238091 10.2196/15385 10.1186/s12877-015-0029-9 10.1007/s40266-020-00812-8 10.3389/fphar.2020.579886 10.1002/rth2.12353 10.1093/ofid/ofaa563 10.1002/cpt.1376 10.2147/TCRM.S259152 10.1007/s11897-020-00485-9 10.1016/j.giec.2019.12.005 10.1001/jama.2020.17021 10.1136/gutjnl-2020-322248
Drugs & Aging; Cattaneo D, Pasina L et. al.
Mar 1st, 2021 - Patients with coronavirus disease 2019 (COVID-19) are often elderly, with comorbidities, and receiving polypharmacy, all of which are known factors for potentially severe drug-drug interactions (DDIs) and the prescription of potentially inappropri...
https://doi.org/10.1002/rmv.2223
Reviews in Medical Virology; Alwani M, Yassin A et. al.
Mar 1st, 2021 - The current coronavirus disease (COVID-19) pandemic caused by novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has a male bias in severity and mortality. This is consistent with previous coronavirus pandemics such as SARS-CoV and...
News 513 results
https://www.fda.gov/media/146217/download
Vaccines and Related Biological Products Advisory Committee Meeting
Feb 25th, 2021 - On February 4, 2021, Janssen Biotech, Inc. (the Sponsor) submitted an Emergency Use Authorization (EUA) request to FDA for an investigational vaccine intended to prevent COVID19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-...
https://www.nejm.org/doi/full/10.1056/NEJMoa2021801
The New England Journal of Medicine; Mitjà O, Corbacho-Monné M et. al.
Feb 2nd, 2021 - Current strategies for preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are limited to nonpharmacologic interventions. Hydroxychloroquine has been proposed as a postexposure therapy to prevent coronavirus disease 2...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422822/
The Journal of Infection; Tomassini S, Kotecha D et. al.
Jan 31st, 2021 - We read with interest the article by Batisse et al.1 describing 11 possible cases of symptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) reinfection. However, the intervening period of ‘clinical cure’ was not confirmed by a ne...
https://www.acpjournals.org/doi/10.7326/M20-7918
Annals of Internal Medicine; Perez J, Roustit M et. al.
Jan 25th, 2021 - Background: A few weeks after the beginning of the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), uncontrolled trials and in vitro studies suggested that chloroquine and hydroxychloroquine may have efficacy in treating c...
https://onlinelibrary.wiley.com/doi/10.1002/jmv.26764
Journal of Medical Virology; Ho, Y.I. et. al.
Jan 10th, 2021 - To the Editor, Various studies have demonstrated that deep throat saliva (DTS) is comparable with nasopharyngeal (NP) specimens for detection of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) by real‐time polymerase chain reaction.1...
